Recap: ReWalk Robotics Q1 Earnings

Shares of ReWalk Robotics RWLK moved higher by 2.4% in pre-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share rose 70.40% over the past year to ($0.37), which missed the estimate of ($0.26).

Revenue of $760,000 decreased by 51.93% year over year, which missed the estimate of $2,200,000.

Outlook

ReWalk Robotics hasn't issued any earnings guidance for the time being.

ReWalk Robotics hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: May 28, 2020

Time: 08:30 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/fm2cohrh

Recent Stock Performance

Company's 52-week high was at $10.08

Company's 52-week low was at $0.41

Price action over last quarter: Up 61.80%

Company Description

ReWalk Robotics Ltd is an Israel based medical device company. It is engaged in designing, developing and commercializing the Rewalk systems which are exoskeletons allowing wheelchair-bound individuals to stand and walk once again. The ReWalk systems allow the users to sit, stand, walk, turn and have the ability to climb and descend stairs. It offers two systems, ReWalk Personal which is designed for every day and all day use by individuals at home and in their communities and is custom-fit for each user; and ReWalk Rehabilitation which is designed for the clinical rehabilitation environment where it provides the user with valuable training exercise and therapy. The company generates maximum revenue from the United States and Europe.